BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15453337)

  • 1. [Interferon therapy for chronic hepatitis B].
    Kakumu S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term history of chronic hepatitis B virus infection in children].
    Fujisawa T; Inui A; Sogo T; Komatsu H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():303-8. PubMed ID: 15453335
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment and selection criteria for chronic hepatitis B].
    Gunji T; Omata M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():309-12. PubMed ID: 15453336
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
    Tang Y; Chen G; Zheng R
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination therapy of lamivudine and HB vaccine for the treatment of chronic hepatitis B].
    Ishikawa T; Kakumu S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():331-5. PubMed ID: 15453340
    [No Abstract]   [Full Text] [Related]  

  • 6. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 8. [A reduction study of seroconversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine].
    Yu SL; Qin LY; Wang C; Yu LJ; Guo CY; Wang YZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):472-3. PubMed ID: 19567034
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lamivudine treatment for hepatitis B].
    Lamivudine Clincal Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):425-8. PubMed ID: 15487066
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B virus infection--natural history and clinical consequences.
    Ganem D; Prince AM
    N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
    [No Abstract]   [Full Text] [Related]  

  • 11. [HBeAg-negative chronic hepatitis].
    Ibragimova MM; Krel' PE; Abdurakhmanov DT
    Ter Arkh; 2004; 76(2):87-91. PubMed ID: 15106425
    [No Abstract]   [Full Text] [Related]  

  • 12. Virus-specific T cell immune response in children and adolescents with chronic hepatitis B virus infection.
    Fischler B; Nyström J; Björnsdottir T; Lindh G; Hultgren C
    J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):75-83. PubMed ID: 17592368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha.
    Pontesilli O; van Nunen AB; van Riel D; Carotenuto P; Niesters HG; Uytdehaag FG; De Man RA; Osterhaus AD
    Liver Int; 2004 Aug; 24(4):308-15. PubMed ID: 15287853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To stop or not to stop: the quest for long-term viral suppression.
    Fung J; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2011 Mar; 26(3):420-2. PubMed ID: 21332537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Corticosteroid withdrawal therapy in patients with chronic hepatitis B virus infection].
    Akuta N; Kumada H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():345-8. PubMed ID: 15453343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
    Wang FS; Zhang JY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis B.
    Lok AS
    N Engl J Med; 2002 May; 346(22):1682-3. PubMed ID: 12037146
    [No Abstract]   [Full Text] [Related]  

  • 19. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H; Zhao ZX; Xu QH; Zhou YP; Chen YM; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.